ReviewContemporary Management of Electrical Storm
Introduction
Electrical storm (ES) is a distinct medical emergency characterised by multiple episodes of sustained ventricular arrhythmia within a short time period, typically 24 hours. In the majority of cases, monomorphic ventricular tachycardia constitutes the primary arrhythmia, however, polymorphic ventricular tachycardia and ventricular fibrillation (VF) are also implicated. In patients without an implantable cardioverter defibrillator (ICD), it is generally accepted that three or more discrete episodes of ventricular arrhythmia within 24 hours, or incessant ventricular arrhythmia for more than 12 hours, constitutes ES [1], [2]. In patients with an ICD, this condition is defined as the occurrence of three or more appropriate device therapies within a 24-hour period, separated from one another by at least 5 minutes [1], [2], [3]. ES predominantly afflicts patients with severe structural heart disease, however, this condition is also reported in those with channelopathies such as Brugada and Long QT Syndrome. Clinical factors associated with a higher incidence of ES include: lower left ventricular ejection fraction, implantation of a secondary prevention ICD, treatment with class I anti-arrhythmic agents, and monomorphic ventricular tachycardia (VT) as the underlying arrhythmia [4]. The development of ES is associated with increased risk of death, heart transplantation and hospitalisation for decompensated cardiac failure [5], [6]. The management of ES requires complex multi-disciplinary care including ICD re-programming, haemodynamic support, the use of antiarrhythmic medications, identification and reversal of precipitating factors, and consideration of catheter ablation and neuraxial modulation. This state-of-the-art review will summarise the contemporary knowledge and treatment of ES.
Section snippets
Incidence Of ES
The overall reported incidence of ES is 10–30% in patients with a secondary prevention ICD, occurring at an average of 4–9 months after ICD implantation [3], [7]. The incidence is 4–7% in patients with a primary prevention ICD, occurring ∼18–24 months after ICD implant [8], [9]. In a longitudinal study of patients with ischaemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM), storm occurred with similar incidence between the two groups (5.8% vs. 6.9%, respectively). This study showed
Mechanism of ES
The pathophysiological mechanisms which underlie ventricular arrhythmia storm are not well characterised. It is likely that there is a complex interplay between enhanced sympathetic tone, calcium-related signalling abnormalities, dysregulation of protein phosphorylation and a susceptible arrythmogenic substrate [10]. The working theory is that three key factors culminate in storm: a vulnerable heart (i.e., presence of pre-existing heart disease that creates the necessary “substrate”), an
Implications of ES
The occurrence of electrical storm has been associated with a mortality rate of up to 14% in the first 48 hours from presentation [18], [19]. The AVID (Antiarrhythmics Versus Implantable Defibrillators) study, which followed patients with secondary prevention ICDs, demonstrated a 5.6-fold increase in mortality in the first 12 weeks subsequent to the development of ES [18]. Similarly, in a subset analysis of the MADIT (Multicenter Automatic Defibrillator Implantation Trial) II trial, the
Overview
The treatment of electrical storm, regardless of underlying aetiology and electrophysiological substrate, requires a multimodal approach. Several therapeutic modalities have been proposed for the treatment of electrical storm including device reprogramming, pharmacotherapy, sedation, neuraxial modulation and radiofrequency catheter ablation. Radiofrequency catheter ablation is emerging as the standard-of-care in patients with electrical storm refractory to optimal medical management. There is
Conclusions
Electrical storm is a distinct arrhythmic emergency which portends significant morbidity and mortality. In the context of increasing use of ICDs in primary and secondary prevention of sudden cardiac death, the occurrence of this clinical phenomenon is likely to increase. Treatment requires a multi-disciplinary approach involving exclusion and treatment of triggers, optimal ICD and/or CRT programming (including turning off a pro-arrhythmic LV lead), anti-arrhythmic drug therapy, sedation,
Acknowledgements
None.
Funding Sources
None.
References (89)
- et al.
EHRA/HRS/APHRS expert consensus on ventricular arrhythmias
Heart Rhythm
(2014) - et al.
Successful ventricular tachycardia ablation in patients with electrical storm reduces recurrences and improves survival
Heart Rhythm
(2018) - et al.
Significant impact of electrical storm on mortality in patients with structural heart disease and an implantable cardiac defibrillator
Int J Cardiol
(2018) - et al.
Electrical storm in patients with transvenous implantable cardioverter- defibrillators: incidence, management and prognostic implications
J Am Coll Cardiol
(1998) - et al.
Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy
Heart Rhythm
(2007) - et al.
Genetic variants in post myocardial infarction patients presenting with electrical storm of unstable ventricular tachycardia
Indian Pacing Electrophysiol J
(2018) - et al.
Ventricular fibrillation-induced intracellular Ca2+ overload causes failed electrical defibrillation and post-shock reinitiation of fibrillation
J Mol Cell Cardiol
(1998) - et al.
Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators
J Am Coll Cardiol
(1999) - et al.
Effects of repeated electrical defibrillations on cardiac troponin I levels
Am J Cardiol
(1999) - et al.
Impact of ventricular tachycardia ablation on health care utilization
Heart Rhythm
(2018)
Catheter ablation of electrical storm in a collaborative hospital network
Am J Cardiol
Implantable cardioverter-defibrillator programming and electrical storm: results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD)
Heart Rhythm
Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: painFree SST trial primary results
Heart Rhythm
Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (primary prevention parameters evaluation) study
J Am Coll Cardiol
The role of the autonomic nervous system in sudden cardiac death
Progress Cardiovasc Dis
Electrical storm and termination with propofol therapy: a case report
Int J Cardiol
Hemodynamic support for ventricular tachycardia ablation
Card Electrophysiol Clin
Comparative effectiveness of antiarrhythmic drugs and catheter ablation for the prevention of recurrent ventricular tachycardia in patients with implantable cardioverter-defibrillators: a systematic review and meta-analysis of randomized controlled trials
Heart Rhythm
Arrhythmogenic effects of antiarrhythmic drugs: a study of 506 patients treated for ventricular tachycardia or fibrillation
J Am Coll Cardiol
Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up
Heart Rhythm
Propranolol versus metoprolol for treatment of electrical storm in patients with implantable cardioverter-defibrillator
J Am Coll Cardiol
Effects of chronic amiodarone therapy on defibrillation threshold
Am J Cardiol
Evaluation of intravenous lidocaine for the termination of sustained monomorphic ventricular tachycardia in patients with coronary artery disease with or without healed myocardial infarction
Am J Cardiol
Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia
Am J Cardiol
Long-term outcomes of catheter ablation of electrical storm in nonischemic dilated cardiomyopathy compared with ischemic cardiomyopathy
JACC: Clin Electrophysiol
Mechanisms and management of refractory ventricular arrhythmias in the age of autonomic modulation
Heart Rhythm
Efficacy of stellate ganglion blockade in managing electrical storm: a systematic review
JACC Clin Electrophysiol
Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery
Heart Rhythm
Bioelectronic neuromodulation of the paravertebral cardiac efferent sympathetic outflow and its effect on ventricular electrical indices
Heart Rhythm
Bioelectronic block of paravertebral sympathetic nerves mitigates post-myocardial infarction ventricular arrhythmias
Heart Rhythm
Mode of initiation and ablation of ventricular fibrillation storms in patients with ischemic cardiomyopathy
J Am Coll Cardiol
Catheter ablation of ventricular fibrillation: importance of left ventricular outflow tract and papillary muscle triggers
Heart Rhythm
Idiopathic ventricular arrhythmias originating from the moderator band: electrocardiographic characteristics and treatment by catheter ablation
Heart Rhythm
Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study
J Am Coll Cardiol
Primary prevention implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy: a meta-analysis
JAMA Cardiol
Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial
Circulation
Role of electrical storm as a mortality and morbidity risk factor and its clinical predictors: a meta-analysis
Europace
Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention
Clin Cardiol
Ca(2 + )-related signaling and protein phosphorylation abnormalities play central roles in a new experimental model of electrical storm
Circulation
Ventricular arrhythmia storm in the era of implantable cardioverter-defibrillator
Postgrad Med J
Early repolarization associated with ventricular arrhythmias in patients with chronic coronary artery disease
Circ Arrhythm Electrophysiol
Beyond the storm: comparison of clinical factors, arrhythmogenic substrate, and catheter ablation outcomes in structural heart disease patients with versus those without a history of ventricular tachycardia storm
J Cardiovasc Electrophysiol
Electrical storm in patients with an implantable defibrillator: incidence, features, and preventive therapy: insights from a randomized trial
Eur Heart J
Electrical storm in patients with implantable cardioverter-defibrillators: can it be forecast?
Tex Heart Inst J
Cited by (41)
Electrical storm in patients with Automatic Implantable Defibrillator : A single Center study
2023, Annales de Cardiologie et d'AngeiologieEarly ganglion stellate blockade as part of two-step treatment algorithm suppresses electrical storm and need for intubation
2023, Hellenic Journal of CardiologyShort-Coupled Idiopathic Ventricular Fibrillation: A Literature Review With Extended Follow-Up
2022, JACC: Clinical ElectrophysiologyStructural and function organization of intrathoracic extracardiac autonomic projections to the porcine heart: Implications for targeted neuromodulation therapy
2022, Heart RhythmCitation Excerpt :These imbalances can be corrected surgically, pharmacologically, or with bioelectric interventions.17,18 Pharmacologic intervention include therapies with limited duration, including anesthetics delivered to the epidural space of the thoracic spinal cord21,29 or stellate ganglia.29 Bioelectric interventions include placing interfaces on the T1–T2 region of the paravertebral chain and using kilohertz AC block30 or charge-balanced DC block31 or epidural electrodes placed over the dorsal columns for spinal cord stimulation.19,32
Brain–heart communication in health and diseases
2022, Brain Research Bulletin